Wave 80 Biosciences, Inc. - Product Pipeline Analysis, 2014 Update - New Market Research Report
Wave 80 Biosciences, Inc. (Wave 80) is a research-driven medical technologies company. It develops molecular diagnostic instruments and consumables for hepatitis B, hepatitis C, HIV/AIDS and other human health conditions. The company harnesses its EOSCAPE molecular diagnostics system, which facilitates provision of molecular testing in smaller hospitals and clinics. Its lead product, EOSCAPE-HIV, is an in vitro nucleic acid assay, which enables the detection and quantitation of human immunodeficiency virus type 1 (HIV-1) RNA. Its product pipeline comprises assays for...
View full press release